Suppr超能文献

[纤维化间质性肺疾病的治疗]

[Treatment of fibrosing interstitial lung diseases].

作者信息

Labrune S, Huchon G

机构信息

Université de Paris René-Descartes, hôpital Ambroise-Paré, service de pneumologie, Boulogne.

出版信息

Rev Prat. 1991 May 11;41(14):1275-7.

PMID:2068520
Abstract

In fibrosing pneumonitis, respiratory insufficiency is due to both fibrosis and inflammation induced pulmonary fibrosis. There is no treatment that can suppress fibrosis, so the current treatment of fibrosing pneumonitis--corticosteroid and/or immunosuppressive drugs--aims at reducing pulmonary inflammation and thus at slowing down the development of fibrosis which cannot regress. Therefore, it is necessary to determine the respective parts of inflammation, potentially reversible, and of fibrosis which is not. Most of the time, respiratory insufficiency cannot be prevented and requires long-term oxygen therapy. In a few patients, lung transplantation must be discussed.

摘要

在纤维化性肺炎中,呼吸功能不全是由纤维化以及炎症引发的肺纤维化所致。目前尚无能够抑制纤维化的治疗方法,因此,纤维化性肺炎当前的治疗手段——使用皮质类固醇和/或免疫抑制药物——旨在减轻肺部炎症,从而减缓无法逆转的纤维化进程。所以,有必要明确炎症(可能具有可逆性)和纤维化(不可逆)各自所起的作用。大多数情况下,呼吸功能不全无法预防,需要长期进行氧疗。少数患者则必须考虑肺移植。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验